# Abuse-Deterrent Opioids-Evaluation and Labeling – FDA Guidance

Source: https://www.keypedia.com/guidances/guidance-document/abuse-deterrent-opioids-evaluation-and-labeling/0a716f45-a359-4eab-aacc-8fba6a24447e

> FDA guidance document: Abuse-Deterrent Opioids-Evaluation and Labeling. Issue date: April 02, 2015. Get complete insights and analysis.

---

## Details

- Title: Abuse-Deterrent Opioids-Evaluation and Labeling
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2015-04-02
- Last Changed: 2022-02-17
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2013-D-0045">FDA-2013-D-0045</a>

## Related Documents

- [Investigational New Drug Applications for Positron Emission Tomography (PET) Drugs](https://www.keypedia.com/guidances/guidance-document/investigational-new-drug-applications-for-positron-emission-tomography-pet-drugs/c3d2d63b-b192-4684-b9ea-880c5065d37b)
- [Codevelopment of Two or More New Investigational Drugs for Use in Combination](https://www.keypedia.com/guidances/guidance-document/codevelopment-of-two-or-more-new-investigational-drugs-for-use-in-combination/6a704e0b-f05e-4e65-91b9-7d60ac493505)
- [Submission of Summary Bioequivalence Data for Abbreviated New Drug Applications](https://www.keypedia.com/guidances/guidance-document/submission-of-summary-bioequivalence-data-for-abbreviated-new-drug-applications/c8804eda-e868-4190-aaf3-700e3b13cf9e)